Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
13.18
+0.05 (0.38%)
Feb 11, 2026, 12:43 PM EST - Market open
Janux Therapeutics Analyst Ratings
Total Analysts
12
Consensus Rating
Buy
Price Target
$57.36
Upside
+335.20%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Clear Street | Clear Street | Strong Buy → Hold Downgrades $32 → $12 | Strong Buy → Hold | Downgrades | $32 → $12 | -8.95% | Jan 20, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $42 → $30 | Buy | Maintains | $42 → $30 | +127.62% | Jan 16, 2026 |
| Barclays | Barclays | Buy Maintains $48 → $29 | Buy | Maintains | $48 → $29 | +120.03% | Dec 17, 2025 |
| Stifel | Stifel | Strong Buy Maintains $46 → $38 | Strong Buy | Maintains | $46 → $38 | +188.32% | Dec 2, 2025 |
| Clear Street | Clear Street | Strong Buy Maintains $80 → $32 | Strong Buy | Maintains | $80 → $32 | +142.79% | Dec 2, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $58 → $49 | Strong Buy | Maintains | $58 → $49 | +271.78% | Dec 2, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $200 → $150 | Buy | Maintains | $200 → $150 | +1,038.09% | Dec 2, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $70 → $45 | Strong Buy | Maintains | $70 → $45 | +241.43% | Dec 2, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $70 | Strong Buy | Reiterates | $70 | +431.11% | Nov 25, 2025 |
| Wolfe Research | Wolfe Research | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Nov 18, 2025 |
| Barclays | Barclays | Buy Maintains $47 → $48 | Buy | Maintains | $47 → $48 | +264.19% | Nov 7, 2025 |
| Barclays | Barclays | Buy Initiates $47 | Buy | Initiates | $47 | +256.60% | Sep 17, 2025 |
| Truist Securities | Truist Securities | Strong Buy Initiates $100 | Strong Buy | Initiates | $100 | +658.73% | Sep 10, 2025 |
| Stifel | Stifel | Strong Buy Initiates $45 | Strong Buy | Initiates | $45 | +241.43% | Sep 10, 2025 |
| Guggenheim | Guggenheim | Strong Buy Initiates $72 | Strong Buy | Initiates | $72 | +446.28% | Sep 4, 2025 |
| Piper Sandler | Piper Sandler | Buy Initiates $42 | Buy | Initiates | $42 | +218.66% | Aug 19, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.